Interspecies Scaling of Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Type I Interferons
Authors:
- 16 March 2010
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 27 (5) , 920-932
Abstract
Purpose To develop an integrated mechanism-based modeling approach for the interspecies scaling of pharmacokinetic (PK) and pharmacodynamic (PD) properties of type I interferons (IFNs) that exhibit target-mediated drug disposition (TMDD). Methods PK and PD profiles of human IFN-β1a, IFN-β1b, and IFN-α2a in humans, monkeys, rats, and mice from nine studies were extracted from the literature by digitization. Concentration-time profiles from different species were fitted simultaneously using various allometric relationships to scale model-specific parameters. Results PK/PD profiles of IFN-β1a in humans and monkeys were successfully characterized by utilizing the same rate constant parameters and scaling the volume of the central compartment to body weight using an allometric exponent of 1. Concentration and effect profiles of other IFNs were also well described by changing only the affinity of the drug to its receptor. PK profiles in rodents were simulated using an allometric exponent of −0.25 for the first-order elimination rate constant, and no receptor-binding was included given the lack of cross-reactivity. Conclusions An integrated TMDD PK/PD model was successfully combined with classic allometric scaling techniques and showed good predictive performance. Several parameters obtained from one IFN can be effectively shared to predict the kinetic behavior of other IFN subtypes.Keywords
This publication has 40 references indexed in Scilit:
- Development of Translational Pharmacokinetic–Pharmacodynamic ModelsClinical Pharmacology & Therapeutics, 2008
- A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry**This work was presented at the American Association of Pharmaceutical Scientists Annual meeting, Salt Lake City, USA, Oct. 26, 2003.Journal of Pharmaceutical Sciences, 2006
- A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALINGDrug Metabolism and Disposition, 2005
- Mini ReviewHuman Interferons Alpha, Beta and OmegaGrowth Factors, 2004
- Pharmacokinetics of Recombinant Human Leukemia Inhibitory Factor in SheepThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Interspecies Scaling of Protein Drugs: Prediction of Clearance from Animals to HumansJournal of Pharmaceutical Sciences, 2004
- Interspecies Scaling of Interferon Disposition and Comparison of Allometric Scaling with Concentration-Time TransformationsJournal of Pharmaceutical Sciences, 1995
- INTERFERONS AND THEIR ACTIONSAnnual Review of Biochemistry, 1987
- The Fate of [ 125 I] -Labeled Human Leukocyte-Derived Alpha Interferon in the RatJournal of Interferon Research, 1985
- Animal scale-upJournal of Pharmacokinetics and Biopharmaceutics, 1973